SHEL Stock Analysis: Shell | NYSE
Oil & Gas Integrated | NYSE, USA | Market Cap: 244.536m USD | 12M Return: 24.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 503M
EPS Trend: -91.1%
Qual. Beats: 1
Rev. Trend: -95.6%
Qual. Beats: -1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Shell plc is a London-headquartered energy and petrochemical company operating globally across five reportable segments: Integrated Gas, Upstream, Marketing, Chemicals and Products, and Renewables and Energy Solutions. Its operations span the full oil and gas value chain, from exploration and extraction of crude oil, natural gas, and natural gas liquids, through LNG production and gas-to-liquids (GTL) processing, to refining, chemicals manufacturing, marketing of fuels and lubricants, and an extensive pipeline and trading business.
In recent years, Shell has expanded into low-carbon energy offerings, including biofuels for aviation, marine, and agricultural customers, as well as electric vehicle charging and convenience retail through its marketing network. Founded in 1907 and originally listed as Royal Dutch Shell, the company adopted its current single-name structure in January 2022 and trades on the NYSE as an ADR under the ticker SHEL, classified within the GICS Energy sector.
The integrated business model-combining upstream production with midstream infrastructure, downstream refining, and chemicals-has historically been the dominant structure among the worlds largest oil majors, allowing these companies to capture margins across multiple stages of the hydrocarbon value chain while diversifying exposure to commodity price cycles.
- Crude oil and gas price swings drive upstream segment margins
- LNG demand and pricing growth supports Integrated Gas cash flows
- Share buyback program accelerates returning surplus capital to shareholders
| Net Income: 18.7b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -2.81 > 1.0 |
| NWC/Revenue: 9.61% < 20% (prev 10.88%; Δ -1.27% < -1%) |
| CFO/TA 0.10 > 3% & CFO 38.9b > Net Income 18.7b |
| Net Debt (83.1b) to EBITDA (56.2b): 1.48 < 3 |
| Current Ratio: 1.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.85b) vs 12m ago -10.37% < -2% |
| Gross Margin: 16.74% > 18% (prev 15.15%; Δ 1.59% > 0.5%) |
| Asset Turnover: 69.43% > 50% (prev 72.21%; Δ -2.78% > 0%) |
| Interest Coverage Ratio: 6.66 > 6 (EBIT TTM 33.4b / Interest Expense TTM 5.02b) |
| A: 0.07 (Total Current Assets 119b - Total Current Liabilities 93.5b) / Total Assets 381b |
| B: 0.50 (Retained Earnings 191b / Total Assets 381b) |
| C: 0.09 (EBIT TTM 33.4b / Avg Total Assets 385b) |
| D: 0.84 (Book Value of Equity 174b / Total Liabilities 206b) |
| Altman-Z'' = 3.55 = A |
| DSRI: 1.17 (Receivables 53.9b/48.2b, Revenue 267b/281b) |
| GMI: 0.90 (GM 15.15% / 16.74%) |
| AQI: 0.98 (AQ_t 0.20 / AQ_t-1 0.20) |
| SGI: 0.95 (Revenue 267b / 281b) |
| TATA: -0.05 (NI 18.7b - CFO 38.9b) / TA 381b) |
| Beneish M = -3.02 (Cap -4..+1) = AA |
As of July 28, 2026, the stock is trading at USD 86.37 with a total of 8,440,534 shares traded. Over the past week, the price has changed by +0.20%, over one month by +12.33%, over three months by +0.28% and over the past year by +24.21%.
Current recommended Stop Loss: 84.00 (which is 2.7% or 1.6 ATR below the current price).
Shell has received a consensus analysts rating of 3.94. Therefore, it is recommended to buy SHEL.
- StrongBuy: 7
- Buy: 1
- Hold: 8
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 97.1 | 12.4% |
P/E Trailing = 13.7664
P/E Forward = 7.7519
P/S = 0.9147
P/B = 1.4088
P/EG = 1.2878
Revenue TTM = 267b USD
EBIT TTM = 33.4b USD
EBITDA TTM = 56.2b USD
Long Term Debt = 40.4b USD (from longTermDebt, last quarter)
Short Term Debt = 10.1b USD (from shortTermDebt, last quarter)
Debt = 106b USD (from shortLongTermDebtTotal, last quarter) + Leases 30.6b
Net Debt = 83.1b USD (calculated: Debt 106b - CCE 23.1b)
Enterprise Value = 328b USD (245b + Debt 106b - CCE 23.1b)
Interest Coverage Ratio = 6.66 (Ebit TTM 33.4b / Interest Expense TTM 5.02b)
EV/FCF = 16.47x (Enterprise Value 328b / FCF TTM 19.9b)
FCF Yield = 6.07% (FCF TTM 19.9b / Enterprise Value 328b)
FCF Margin = 7.44% (FCF TTM 19.9b / Revenue TTM 267b)
Net Margin = 7.01% (Net Income TTM 18.7b / Revenue TTM 267b)
Gross Margin = 16.74% ((Revenue TTM 267b - Cost of Revenue TTM 223b) / Revenue TTM)
Gross Margin QoQ = 19.28% (prev 15.63%)
Tobins Q-Ratio = 0.86 (Enterprise Value 328b / Total Assets 381b)
Interest Expense / Debt = 4.73% (Interest Expense 5.02b / Debt 106b)
Taxrate = 36.93% (11.1b / 30.1b)
NOPAT = 21.1b (EBIT 33.4b * (1 - 36.93%))
Current Ratio = 1.27 (Total Current Assets 119b / Total Current Liabilities 93.5b)
Debt / Equity = 0.61 (Debt 106b / totalStockholderEquity, last quarter 174b)
Debt / EBITDA = 1.48 (Net Debt 83.1b / EBITDA 56.2b)
Debt / FCF = 4.18 (Net Debt 83.1b / FCF TTM 19.9b)
Total Stockholder Equity = 176b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.87% (Net Income 18.7b / Total Assets 381b)
RoE = 10.64% (Net Income TTM 18.7b / Total Stockholder Equity 176b)
RoCE = 15.44% (EBIT 33.4b / Capital Employed (Equity 176b + L.T.Debt 40.4b))
RoIC = 7.43% (NOPAT 21.1b / Invested Capital 284b)
WACC = 5.83% (E(245b)/V(351b) * Re(7.06%) + D(106b)/V(351b) * Rd(4.73%) * (1-Tc(0.37)))
Discount Rate = 7.06% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.68 | Cagr: -6.48%
[DCF] Terminal Value 73.10% ; FCFF base≈24.4b ; Y1≈21.4b ; Y5≈17.3b
[DCF] Fair Price = 70.42 (EV 278b - Net Debt 83.1b = Equity 195b / Shares 2.77b; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -91.05 | EPS CAGR: -13.30% | SUE: 0.91 | # QB: 1
Revenue Correlation: -95.63 | Revenue CAGR: -9.73% | SUE: -1.23 | # QB: -1
EPS current Quarter (2026-06-30): EPS=3.16 | Chg30d=+7.48% | Revisions=+0% | Analysts=6
EPS next Quarter (2026-09-30): EPS=2.59 | Chg30d=-9.45% | Revisions=-40% | Analysts=6
EPS current Year (2026-12-31): EPS=10.05 | Chg30d=-5.39% | Revisions=-50% | GrowthEPS=+59.5% | GrowthRev=+17.2%
EPS next Year (2027-12-31): EPS=8.72 | Chg30d=-7.20% | Revisions=-29% | GrowthEPS=-13.2% | GrowthRev=-7.3%
[Analyst] Revisions Ratio: -50% (up=2, down=9)